30 Papers
257 Citations
B. Serrou is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Cytotoxic T cell & Population. The author has an hindex of 10, co-authored 30 publications.
Chat about Author
Papers
Increased sensitivity of IL2-dependent cultured T cells and enhancement of in vitro IL2 production by human lymphocytes treated with Bestatin
TL;DR: This study focuses on the effect of Bestatin on interleukin 2 (IL2) sensitivity of IL2-dependent cultured T cells (CTC) and on IL2 production by human peripheral blood mononuclear cells (PBM).
40
Diminished interleukin-2 activity production in cancer patients bearing solid tumors and its relationship with natural killer cells.
TL;DR: Results might suggest a central role for IL-2 in the immune dysfunctions in cancer patients, and the possible use ofIL-2 as an immunological response modifier in these patients.
38
Human autologous rosettes. I. Mechanism of binding of autologous erythrocytes by T cells.
TL;DR: A population of human peripheral blood lymphocytes is able to bind autologous erythrocytes in the presence of autOLOGous serum, and the 26% RFC obtained with an optimized assay are related to the T-cell lineage.
36
The role of interleukin 1 and interleukin 2 in human T colony formation.
TL;DR: Results suggest that TCPA and IL2 are related entities, and the fact that IL2 participates in T colony formation suggests that monocytes induce T colonies formation through IL2 production.
26
Human Autologous Rosettes. II. Prognostic Significance of Variations in Autologous Rosette-Forming Cells in the Peripheral Blood of Cancer Patients
TL;DR: Dim diminution of this pertinent subset of T-lymphocytes has interesting clinical value by its being closely related to an adverse prognosis.
24